Showing results (451-460 of 594) with videos related to
Sort By:
Pageof 60
Frontiers in Public Health|May 27, 2026
Challenges to continuity of care among patients with long COVID-related taste and smell disorders: a qualitative studyMaría Belén Martín-Sanz, Paloma Moro-López-Menchero, César Fernández-De-Las-Peñas, et al.Scientific Reports|October 23, 2019
EV-associated miRNAs from pleural lavage as potential diagnostic biomarkers in lung cancerBerta Roman-Canal, Cristian Pablo Moiola, Sònia Gatius, et al.Viruses|February 24, 2024
Inflammatory Polymorphisms (IL-6 <i>rs1800796</i>, IL-10 <i>rs1800896</i>, TNF-α <i>rs1800629</i>, and IFITM3 <i>rs12252</i>) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 SurvivorsCésar Fernández-de-Las-Peñas, Gema Díaz-Gil, Antonio Gil-Crujera, et al.JAMA Neurology|December 3, 2019
Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical TrialRima Nabbout, Arun Mistry, Sameer Zuberi, et al.Molecular Oncology|April 28, 2026
Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off-the-shelf targeted NGS panelCarlos Casas-Arozamena, Karin Teien Lande, Eva Diaz, et al.Molecular Plant-Microbe Interactions : MPMI|November 10, 2016
Sinorhizobium fredii HH103 Invades Lotus burttii by Crack Entry in a Nod Factor-and Surface Polysaccharide-Dependent MannerSebastián Acosta-Jurado, Dulce-Nombre Rodríguez-Navarro, Yasuyuki Kawaharada, et al.Epilepsy & Behavior : E&B|May 19, 2022
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision AnalysisAntonio Gil-Nagel, Mercè Falip, Rocío Sánchez-Carpintero, et al.International Journal of Molecular Sciences|March 13, 2025
DNA Salivary Methylation Levels of the ACE2 Promoter Are Not Related to ACE2 (<i>rs2285666</i> and <i>rs2074192</i>), TMPRSS2 (<i>rs12329760</i> and <i>rs2070788</i>) and ACE1 <i>rs1799752</i> Polymorphisms in COVID-19 Survivors with Post-COVID-19 ConditionCésar Fernández-de-Las-Peñas, Gema Díaz-Gil, Antonio Gil-Crujera, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2024
Outcomes of minimal residual disease at upfront debulking surgery compared with complete cytoreduction after neoadjuvant chemotherapyVioleta Romero, Martina Aida Angeles, Elena Rodríguez González, et al.Annals of Surgical Oncology|July 23, 2025
The MULTISENT Study: A Multicenter Study on the Detection Rate of Sentinel Lymph Node Mapping in Endometrial Cancer Across SpainNatalia R Gómez-Hidalgo, Silvia Cabrera, Vicente Bebia, et al.Pageof 60